Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2019

Chromosome 17 centromere amplification and chromosomal instability (CIN) in breast cancer: Pathogenic and therapeutic implications
Authors: I. A. Voutsadakis
Neoplasma Vol.66, No.6, p.859–869, 2019
doi:10.4149/neo_2019_190309N203
Price: free access
[View Abstract]


Expression pattern of estrogen receptor β and its correlation with multidrug resistance in non-small cell lung cancer
Authors: L. Huang, T. Liu, H. Ji, S. Yang, J. Sui, W. S. Yang, G. Y. Liang, X. M. Zhang
Neoplasma Vol.66, No.5, p.847–857, 2019
doi:10.4149/neo_2018_181120N872
[View Abstract]


Differential expression of sonic hedgehog in lung adenocarcinoma and lung squamous cell carcinoma
Authors: L. Xu, H. Xiong, W. Shi, F. Zhou, M. Zhang, G. Hu, J. Mei, S. Luo, L. Chen
Neoplasma Vol.66, No.5, p.839–846, 2019
doi:10.4149/neo_2018_181228N1002
[View Abstract]


Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma
Authors: M. Jirkovska, T. Novak, B. Malinova, R. Lohynska
Neoplasma Vol.66, No.5, p.830–838, 2019
doi:10.4149/neo_2018_181209N941
[View Abstract]


Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma
Authors: S. J. YI, P. LIU, B. L. CHEN, L. OU-YANG, W. M. XIONG, J. P. SU
Neoplasma Vol.66, No.5, p.825–829, 2019
doi:10.4149/neo_2018_181109N847
[View Abstract]


Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approache
Authors: O. Fabri, J. Horakova, I. Bodova, P. Svec, Z. Laluhova Striezencova, E. Bubanska, M. Cermak, V. Galisova, K. Skalicka, A. Vaska, D. Doczyova, A. Panikova, T. Sykora, J. Adamcakova, A. Kolenova
Neoplasma Vol.66, No.5, p.818–824, 2019
doi:10.4149/neo_2018_181231N1009
[View Abstract]


The prognostic value of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system in triple-negative breast cancer
Authors: J. P. LI, X. M. ZHANG, Y. S. ZHANG, L. H. ZHENG, Y. J. LIU
Neoplasma Vol.66, No.5, p.810–817, 2019
doi:10.4149/neo_2019_190107N26
[View Abstract]


Association between p53 protein phosphorylated at serine 20 expression and ovarian carcinoma stem cells phenotype: correlation with clinicopathological parameters of ovarian cancer
Authors: J. Bar, P. Grelewski, I. Deszcz, L. Noga, L. Hirnle, A. Lis-Nawara
Neoplasma Vol.66, No.5, p.801–809, 2019
doi:10.4149/neo_2018_181012N764
[View Abstract]


NKAP plays an oncogenic function partly through AKT signaling pathway in hepatocellular carcinoma
Authors: T. Song, J. Y. Liu, J. J. Yang
Neoplasma Vol.66, No.5, p.792–800, 2019
doi:10.4149/neo_2018_181212N957
[View Abstract]


FPR2 enhances colorectal cancer progression by promoting EMT process
Authors: J. Lu, J. Zhao, C. Jia, L. Zhou, Y. Cai, J. Ni, J. Ma, M. Zheng, A. Lu
Neoplasma Vol.66, No.5, p.785–791, 2019
doi:10.4149/neo_2018_181123N890
[View Abstract]


The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells
Authors: L. Mai, M. Luo, J. J. Wu, J. H. Yang, L. Y. Hong
Neoplasma Vol.66, No.5, p.776–784, 2019
doi:10.4149/neo_2018_180921N708
[View Abstract]


Zoledronic acid modulates human osteosarcoma cells proliferation via GSK-3β activation
Authors: S. Li, J. J. Li
Neoplasma Vol.66, No.5, p.766–775, 2019
doi:10.4149/neo_2018_181128N904
[View Abstract]


Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway
Authors: S. L. Shi, Z. H. Zhang
Neoplasma Vol.66, No.5, p.756–765, 2019
doi:10.4149/neo_2018_181218N980
Price: free access
[View Abstract]


MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4
Authors: L. Tao, Y. Q. Wu, S. P. Zhang
Neoplasma Vol.66, No.5, p.746–755, 2019
doi:10.4149/neo_2018_181207N930
[View Abstract]


Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer
Authors: L. Liu, S. Q. Wu, X. Zhu, R. Xu, K. Ai, L. Zhang, X. K. Zhao
Neoplasma Vol.66, No.5, p.736–745, 2019
doi:10.4149/neo_2019_190107N25
[View Abstract]


TRIM31 promotes proliferation, invasion and migration of glioma cells through Akt signaling pathway
Authors: G. Shi, C. Lv, Z. Yang, T. Qin, L. Sun, P. Pan, D. Wang
Neoplasma Vol.66, No.5, p.727–735, 2019
doi:10.4149/neo_2019_190106N21
[View Abstract]


The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis
Authors: H. ZHANG, D. X. ZHANG, T. JU, J. ZHOU
Neoplasma Vol.66, No.5, p.717–726, 2019
doi:10.4149/neo_2018_181213N965
[View Abstract]


MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1
Authors: X. Zhang, K Jin, J. D. Luo, B. Liu, L. P. Xie
Neoplasma Vol.66, No.5, p.704–716, 2019
doi:10.4149/neo_2018_181105N825
[View Abstract]


Receptor interacting protein kinase 3 promotes cisplatin-induced necroptosis in apoptosis-resistant HepG2/DDP cells
Authors: B. Zhang, K. Cao, Z. Liu, W. Shan, Q. Wen, R. Wang
Neoplasma Vol.66, No.5, p.694–703, 2019
doi:10.4149/neo_2018_180710N466
[View Abstract]


Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis
Authors: D. TANG, Q. WU, Z. YUAN, J. XU, H. ZHANG, Z. JIN, Q. ZHANG, M. XU, Z. WANG, Z. DAI , H. FANG, Z. LI, C. LIN, C. SHI, M. XU, X. SUN, D. WANG
Neoplasma Vol.66, No.5, p.681–693, 2019
doi:10.4149/neo_2018_181020N786
[View Abstract]





Display #  
Results 21 - 40 of 121

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.